Structure–Function Analyses of Multidrug Transporters
暂无分享,去创建一个
R. Cannon | G. Madani | M. Niimi | E. Lamping | Hee Ji Lee
[1] Jonathan C. Cohen,et al. Crystal structure of the human sterol transporter ABCG5/ABCG8 , 2016, Nature.
[2] P. Nordlund,et al. Understanding transport by the major facilitator superfamily (MFS): structures pave the way , 2016, Nature Reviews Molecular Cell Biology.
[3] S. Iwata,et al. Structure and mechanism of the mammalian fructose transporter GLUT5 , 2015, Nature.
[4] Richard Henderson,et al. Overview and future of single particle electron cryomicroscopy. , 2015, Archives of biochemistry and biophysics.
[5] Kutti R Vinothkumar,et al. Membrane protein structures without crystals, by single particle electron cryomicroscopy , 2015, Current opinion in structural biology.
[6] Nieng Yan,et al. Structural Biology of the Major Facilitator Superfamily Transporters. , 2015, Annual review of biophysics.
[7] R. Prasad,et al. Mutational Analysis of Intracellular Loops Identify Cross Talk with Nucleotide Binding Domains of Yeast ABC Transporter Cdr1p , 2015, Scientific Reports.
[8] S. Ambudkar,et al. The multidrug transporter Pdr5 on the 25th anniversary of its discovery: an important model for the study of asymmetric ABC transporters. , 2015, The Biochemical journal.
[9] P. Penczek,et al. A Primer to Single-Particle Cryo-Electron Microscopy , 2015, Cell.
[10] B. Carragher,et al. Distinct conformational spectrum of homologous multidrug ABC transporters. , 2015, Structure.
[11] A. Sangamwar,et al. Translocation mechanism of P-glycoprotein and conformational changes occurring at drug-binding site: Insights from multi-targeted molecular dynamics. , 2014, Biochimica et biophysica acta.
[12] Miguel C. Teixeira,et al. MFS multidrug transporters in pathogenic fungi: do they have real clinical impact? , 2014, Front. Physiol..
[13] C. Sorzano,et al. 3D cryo-electron reconstruction of BmrA, a bacterial multidrug ABC transporter in an inward-facing conformation and in a lipidic environment. , 2014, Journal of molecular biology.
[14] Jacqueline E. Schein,et al. Analysis of the Genome and Transcriptome of Cryptococcus neoformans var. grubii Reveals Complex RNA Expression and Microevolution Leading to Virulence Attenuation , 2014, PLoS genetics.
[15] Stephen G Aller,et al. Refined structures of mouse P-glycoprotein , 2013, Protein science : a publication of the Protein Society.
[16] S. Ambudkar,et al. The Deviant ATP-binding Site of the Multidrug Efflux Pump Pdr5 Plays an Active Role in the Transport Cycle* , 2013, The Journal of Biological Chemistry.
[17] P. Biggin,et al. Substrate versus inhibitor dynamics of P‐glycoprotein , 2013, Proteins.
[18] E. Pardon,et al. Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain , 2013, Proceedings of the National Academy of Sciences.
[19] R. Prasad,et al. Insight into Pleiotropic Drug Resistance ATP-binding Cassette Pump Drug Transport through Mutagenesis of Cdr1p Transmembrane Domains* , 2013, The Journal of Biological Chemistry.
[20] Jianping Ding,et al. Crystal structure of a folate energy-coupling factor transporter from Lactobacillus brevis , 2013, Nature.
[21] Tamir Gonen,et al. Overview of Electron Crystallography of Membrane Proteins: Crystallization and Screening Strategies Using Negative Stain Electron Microscopy , 2013, Current protocols in protein science.
[22] J. Stindt,et al. Functional impact of a single mutation within the transmembrane domain of the multidrug ABC transporter Pdr5. , 2013, Biochemistry.
[23] N. Yan. Structural advances for the major facilitator superfamily (MFS) transporters. , 2013, Trends in biochemical sciences.
[24] Rohitash Kumar,et al. Candida albicans Flu1-Mediated Efflux of Salivary Histatin 5 Reduces Its Cytosolic Concentration and Fungicidal Activity , 2013, Antimicrobial Agents and Chemotherapy.
[25] M. Kołaczkowski,et al. A conserved interdomain communication pathway of pseudosymmetrically distributed residues affects substrate specificity of the fungal multidrug transporter Cdr1p. , 2013, Biochimica et biophysica acta.
[26] S. Ambudkar,et al. The Transmission Interface of the Saccharomyces cerevisiae Multidrug Transporter Pdr5: Val-656 Located in Intracellular Loop 2 Plays a Major Role in Drug Resistance , 2012, Antimicrobial Agents and Chemotherapy.
[27] B. Rochat,et al. Milbemycins: More than Efflux Inhibitors for Fungal Pathogens , 2012, Antimicrobial Agents and Chemotherapy.
[28] A. Goffeau,et al. Yeast ATP-binding cassette transporters conferring multidrug resistance. , 2012, Annual review of microbiology.
[29] R. Cannon,et al. Specific interactions between the Candida albicans ABC transporter Cdr1p ectodomain and a d‐octapeptide derivative inhibitor , 2012, Molecular microbiology.
[30] A. M. George,et al. Perspectives on the structure-function of ABC transporters: the Switch and Constant Contact models. , 2012, Progress in biophysics and molecular biology.
[31] R. Prasad,et al. A key structural domain of the Candida albicans Mdr1 protein. , 2012, The Biochemical journal.
[32] Jue Chen,et al. Crystal structure of the multidrug transporter P-glycoprotein from C. elegans , 2012, Nature.
[33] S. Iwata,et al. Alternating access mechanism in the POT family of oligopeptide transporters , 2012, The EMBO journal.
[34] M. Saier,et al. The major facilitator superfamily (MFS) revisited , 2012, The FEBS journal.
[35] Koichi Tanabe,et al. Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function , 2011, Molecular microbiology.
[36] L. Schmitt,et al. The multidrug transporter Pdr5: a molecular diode? , 2011, Biological chemistry.
[37] L. Esser,et al. Toward understanding the mechanism of action of the yeast multidrug resistance transporter Pdr5p: a molecular modeling study. , 2011, Journal of structural biology.
[38] O. Prakash,et al. Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans. , 2010, European journal of medicinal chemistry.
[39] S. Ambudkar,et al. Divergent signature motifs of nucleotide binding domains of ABC multidrug transporter, CaCdr1p of pathogenic Candida albicans, are functionally asymmetric and noninterchangeable. , 2010, Biochimica et biophysica acta.
[40] Z. Sauna,et al. The signaling interface of the yeast multidrug transporter Pdr5 adopts a cis conformation, and there are functional overlap and equivalence of the deviant and canonical Q-loop residues. , 2010, Biochemistry.
[41] A. Driessen,et al. Phylogenetic analysis of fungal ABC transporters , 2010, BMC Genomics.
[42] Lutz Schmitt,et al. Multidrug efflux pumps: Substrate selection in ATP‐binding cassette multidrug efflux pumps – first come, first served? , 2010, The FEBS journal.
[43] A. Goffeau,et al. Fungal PDR transporters: Phylogeny, topology, motifs and function. , 2010, Fungal genetics and biology : FG & B.
[44] A. M. George,et al. Multidrug efflux pumps: The structures of prokaryotic ATP‐binding cassette transporter efflux pumps and implications for our understanding of eukaryotic P‐glycoproteins and homologues , 2010, The FEBS journal.
[45] A. M. George,et al. ABC transporters: a riddle wrapped in a mystery inside an enigma. , 2009, Trends in biochemical sciences.
[46] Ingebrigt Sylte,et al. Theoretical Biology and Medical Modelling Open Access Binding Site of Abc Transporter Homology Models Confirmed by Abcb1 Crystal Structure , 2022 .
[47] J. J. Coleman,et al. Efflux in Fungi: La Pièce de Résistance , 2009, PLoS pathogens.
[48] A. M. George,et al. Opening of the ADP‐bound active site in the ABC transporter ATPase dimer: Evidence for a constant contact, alternating sites model for the catalytic cycle , 2009, Proteins.
[49] S. Ambudkar,et al. The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport. , 2009, Biochimica et biophysica acta.
[50] A. Goffeau,et al. Efflux-Mediated Antifungal Drug Resistance , 2009, Clinical Microbiology Reviews.
[51] Yue Weng,et al. Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.
[52] D. Rees,et al. ABC transporters: the power to change , 2009, Nature Reviews Molecular Cell Biology.
[53] M. Raymond,et al. Relative Contributions of the Candida albicans ABC Transporters Cdr1p and Cdr2p to Clinical Azole Resistance , 2009, Antimicrobial Agents and Chemotherapy.
[54] Miguel C. Teixeira,et al. Drug:H+ antiporters in chemical stress response in yeast. , 2009, Trends in microbiology.
[55] Z. Sauna,et al. Mutations Define Cross-talk between the N-terminal Nucleotide-binding Domain and Transmembrane Helix-2 of the Yeast Multidrug Transporter Pdr5 , 2008, Journal of Biological Chemistry.
[56] D. Choudhury,et al. MFS transportome of the human pathogenic yeast Candida albicans , 2008, BMC Genomics.
[57] Da-Neng Wang,et al. Ins and outs of major facilitator superfamily antiporters. , 2008, Annual review of microbiology.
[58] Koichi Tanabe,et al. ABC Transporter Cdr1p Contributes More than Cdr2p Does to Fluconazole Efflux in Fluconazole-Resistant Candida albicans Clinical Isolates , 2008, Antimicrobial Agents and Chemotherapy.
[59] H. V. van Veen,et al. Multidrug transport by the ABC transporter Sav1866 from Staphylococcus aureus. , 2008, Biochemistry.
[60] P. D. Rogers,et al. Mutations in the multi‐drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole‐resistant Candida albicans strains , 2008, Molecular microbiology.
[61] F. Robert,et al. Genomewide Location Analysis of Candida albicans Upc2p, a Regulator of Sterol Metabolism and Azole Drug Resistance , 2008, Eukaryotic Cell.
[62] K. Kuchler,et al. A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5 , 2008, Proceedings of the National Academy of Sciences.
[63] Geoffrey Chang,et al. Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.
[64] Stephan Kopp,et al. Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP. , 2007, Biochemistry.
[65] R. Homayouni,et al. The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans , 2007, PLoS pathogens.
[66] R. Homayouni,et al. Genome-Wide Expression and Location Analyses of the Candida albicans Tac1p Regulon , 2007, Eukaryotic Cell.
[67] K. Locher,et al. Asymmetry in the Structure of the ABC Transporter-Binding Protein Complex BtuCD-BtuF , 2007, Science.
[68] D. Diogo,et al. Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates , 2007, Eukaryotic Cell.
[69] R. Dawson,et al. Structure and mechanism of ABC transporter proteins. , 2007, Current opinion in structural biology.
[70] Y. Uehara,et al. Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae , 2007, Eukaryotic Cell.
[71] Leopold May,et al. The yeast Pdr5p multidrug transporter: how does it recognize so many substrates? , 2007, Biochemical and biophysical research communications.
[72] K. Locher,et al. Structure of an ABC transporter in complex with its binding protein , 2007, Nature.
[73] K. Locher,et al. Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP , 2007, FEBS letters.
[74] R. Prasad,et al. Structure and Function Analysis of CaMdr1p, a Major Facilitator Superfamily Antifungal Efflux Transporter Protein of Candida albicans: Identification of Amino Acid Residues Critical for Drug/H+ Transport , 2007, Eukaryotic Cell.
[75] S. Ambudkar,et al. Conserved Asp327 of walker B motif in the N-terminal nucleotide binding domain (NBD-1) of Cdr1p of Candida albicans has acquired a new role in ATP hydrolysis. , 2006, Biochemistry.
[76] R. Dawson,et al. Structure of a bacterial multidrug ABC transporter , 2006, Nature.
[77] G. Chang,et al. Structure of the Multidrug Transporter EmrD from Escherichia coli , 2006, Science.
[78] M. Boutry,et al. Organization and function of the plant pleiotropic drug resistance ABC transporter family , 2006, FEBS letters.
[79] D. Choudhury,et al. Complete Inventory of ABC Proteins in Human Pathogenic Yeast, Candida albicans , 2005, Journal of Molecular Microbiology and Biotechnology.
[80] S. Shukla,et al. Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux. , 2005, The Journal of antimicrobial chemotherapy.
[81] George Newport,et al. A Human-Curated Annotation of the Candida albicans Genome , 2005, PLoS genetics.
[82] D. Hirata,et al. Mutational analysis of the yeast multidrug resistance ABC transporter Pdr5p with altered drug specificity , 2005, Genes to cells : devoted to molecular & cellular mechanisms.
[83] K. Hiraga,et al. Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae. , 2005, Biochemical and biophysical research communications.
[84] D. Sanglard,et al. TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2 , 2004, Eukaryotic Cell.
[85] K. Linton,et al. The ATP switch model for ABC transporters , 2004, Nature Structural &Molecular Biology.
[86] K. Locher. Structure and mechanism of ABC transporters. , 2004, Current opinion in structural biology.
[87] S. Ambudkar,et al. Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520. , 2004, The Journal of antimicrobial chemotherapy.
[88] Smriti,et al. Functional Characterization of Candida albicans ABC Transporter Cdr1p , 2003, Eukaryotic Cell.
[89] C. Higgins,et al. Three-dimensional Structures of the Mammalian Multidrug Resistance P-glycoprotein Demonstrate Major Conformational Changes in the Transmembrane Domains upon Nucleotide Binding* , 2003, The Journal of Biological Chemistry.
[90] M. Gottesman,et al. Studies with Novel Pdr5p Substrates Demonstrate a Strong Size Dependence for Xenobiotic Efflux* , 2003, The Journal of Biological Chemistry.
[91] T. Yamada-Okabe,et al. Characterization of the CaNAG3, CaNAG4, and CaNAG6 genes of the pathogenic fungus Candida albicans: possible involvement of these genes in the susceptibilities of cytotoxic agents. , 2002, FEMS microbiology letters.
[92] T. C. White,et al. Resistance Mechanisms in Clinical Isolates of Candida albicans , 2002, Antimicrobial Agents and Chemotherapy.
[93] D. Sanglard,et al. A common drug‐responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance , 2002, Molecular microbiology.
[94] M. Arisawa,et al. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients. , 2001, The Journal of antimicrobial chemotherapy.
[95] J. Galazzo,et al. Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance. , 2001, Farmaco.
[96] O. Lambert,et al. Use of detergents in two-dimensional crystallization of membrane proteins. , 2000, Biochimica et biophysica acta.
[97] D. Sanglard,et al. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. , 2000, Microbiology.
[98] A. Seelig,et al. Structure-activity relationship of P-glycoprotein substrates and modifiers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[99] J. Morschhäuser,et al. Targeted gene disruption in Candida albicans wild‐type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates , 2000, Molecular microbiology.
[100] K. Kuchler,et al. The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility , 2000, Molecular microbiology.
[101] K. Kuchler,et al. Genetic separation of FK506 susceptibility and drug transport in the yeast Pdr5 ATP-binding cassette multidrug resistance transporter. , 1998, Molecular biology of the cell.
[102] T. C. White,et al. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus , 1997, Antimicrobial agents and chemotherapy.
[103] K. Yamamoto,et al. An FK506-sensitive Transporter Selectively Decreases Intracellular Levels and Potency of Steroid Hormones* , 1996, The Journal of Biological Chemistry.
[104] I. Paulsen,et al. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[105] K. Kuchler,et al. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters , 1995, Antimicrobial agents and chemotherapy.
[106] I. Paulsen,et al. Topology, structure and evolution of two families of proteins involved in antibiotic and antiseptic resistance in eukaryotes and prokaryotes--an analysis. , 1993, Gene.
[107] J. A. Gorman,et al. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate , 1991, Molecular and General Genetics MGG.
[108] J. Walker,et al. Distantly related sequences in the alpha‐ and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐requiring enzymes and a common nucleotide binding fold. , 1982, The EMBO journal.
[109] C. Su,et al. Crystallization of membrane proteins by vapor diffusion. , 2015, Methods in enzymology.
[110] M. Perlin,et al. Essential letters in the fungal alphabet: ABC and MFS transporters and their roles in survival and pathogenicity. , 2014, Advances in genetics.
[111] R. Cannon,et al. Use of a yeast-based membrane protein expression technology to overexpress drug resistance efflux pumps. , 2010, Methods in molecular biology.
[112] Geoffrey Chang,et al. Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1. , 2010, Trends in biochemical sciences.